Physician profile
Heather Fahey
NPI 1649625724
$3,989.22
in general payments reported to CMS, 2019-2025
15 companies · $661 in 2025
The $661 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $496 · 2021: $762 · 2022: $1,203 · 2023: $604 · 2024: $264 · 2025: $661.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,529.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,528.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,740.37 | 2020-2025 | Gallant, Cardiomems, Navitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $502.10 | 2020-2023 | Lifevest |
| Abiomed | $419.79 | 2020-2025 | Impella |
| Amgen INC. | $242.84 | 2021-2023 | |
| Boston Scientific Corporation | $203.40 | 2025 | Avvigo Guidance System |
| Medtronic, INC. | $171.87 | 2022-2025 | Symplicity G3 |
| Zoll Circulation INC | $146.40 | 2022 | |
| Cook Incorporated | $140.85 | 2020 | |
| Cardiovascular Systems INC. | $117.25 | 2022 | |
| Novartis Pharmaceuticals Corporation | $102.63 | 2024-2025 | |
| Asahi Intecc USA, INC. | $79.85 | 2025 | Asahi Peripheral Vascular Wires, Asahi Coronary Wires |
| Pfizer INC. | $53.67 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $26.46 | 2025 | Verquvo |
| Philips North America LLC | $25.81 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $15.93 | 2024 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Fahey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.